Navigation Links
Cardiorobotics Closes $11.6M Series A Financing to Advance Clinical Development of Snake Robot for Surgery
Date:7/24/2009

PITTSBURGH, July 24 /PRNewswire/ -- Cardiorobotics, Inc., a medical device company developing snake robot technologies for use in a wide range of surgical and interventional applications has closed on an $11.6 Million private equity Series A round of financing. The round was led by Eagle Ventures and its co-investors, the Pittsburgh Life Sciences Greenhouse and the Slater Technology Fund and affiliated investors.

Funds raised in this round will support the advancement of the clinical product, a clinical feasibility trial on humans, and completion of commercial product for regulatory approval in the United States and the European Union.

"This investment will be used to advance our core product, the cardioARM(TM), toward commercialization," said Dr. Samuel Straface, Cardiorobotics, Inc., president and Chief Executive Officer. "We're pleased to have Eagle Ventures, the Pittsburgh Life Sciences Greenhouse, and the Slater Technology Fund and affiliated investors share our vision in providing single-port, off-pump treatments for patients with heart arrhythmias."

"I am impressed by the combination of the breakthrough technology platform, experienced entrepreneurial leadership, and high commercialization potential of the cardioARM(TM)," said Mel Pirchesky, president and Chief Executive Officer of Eagle Ventures. "In particular, I was very impressed by the leadership's talent and really amazed to learn that the company's system could convert a complex heart procedure that requires a heart-lung machine, into a single-port, minimally invasive one of about an hour's duration without the heart-lung machine."

Cardiorobotics' is the global leader in snake robotics for minimally-invasive cardiac interventions, allowing minimally invasive treatments for patients suffering with heart arrhythmias. Cardiac surgery is currently the gold standard invasive treatment option for patients with chronic heart arrhythmias, such as atrial fibrillation, but requires a large breastplate incision to access the heart as well as general endotracheal anesthesia. The heart-lung machine that is required for open-heart surgery (e.g. valve repair) adds further morbidity. Performing a single-port epicardial (outside the heart) intervention in a less invasive manner will dramatically improve patient recovery and significantly decrease risks involved with the current procedures.

About Cardiorobotics, Inc.

Cardiorobotics, Inc. is developing snake robot technologies for use in a wide range of surgical and interventional applications. The Company's products have very high degrees of freedom of movement, are tele-operated, and are able to steer a self-supported, non-linear path from a single access port and deploy an array of special tools and imaging technologies.

Within the medical field, the company plans ultimately to serve a number of different specialist areas, including: minimally-invasive cardiac surgery, cardiac electrophysiology, NOTES and a range of single-port abdominal and thoracic procedures. Cardiorobotics employs thirteen people at its Technology & Research Center in Pittsburgh, PA and the business and product development facility located in Newport, RI. The Company is in its pre-clinical stage and expects to begin its first human clinical trials in 2009. For more information visit www.cardiorobotics.com.

About Eagle Ventures

Eagle Ventures is a Shadyside-based private equity firm that helps entrepreneurs develop the articulation of their value proposition and secure the funding they deserve from select groups of angel investors. Mel Pirchesky, its president and CEO, and an entrepreneur himself, and has raised over $63 million of private equity solely from high net worth individuals mostly from the Pittsburgh region. These funds have been deployed almost entirely in western PA entrepreneurial opportunities. Eagle's current focus is financing medical device startups and acquiring small profitable manufacturing companies. On the personal side, Mel Pirchesky's lifetime commitment is to create a level playing field for low-income youngsters. He manifests this by strongly promoting the expansion of the Greater Pittsburgh Council of the Boy Scouts of America's Scoutreach Program to include really hard-to-reach youngsters. For more information, visit www.EagleVentures.biz.

About Pittsburgh Life Sciences Greenhouse

The Pittsburgh Life Sciences Greenhouse (PLSG) provides capital investments and customized company formation and business growth services to western Pennsylvania's life sciences enterprises. The PLSG supports biosciences companies with promising innovations in the following concentrations: Biotechnology Tools, Diagnostics, Healthcare IT, Medical Devices and Therapeutics. The PLSG is propelling the sustainable growth of the region's life sciences economy by accelerating research and technology commercialization with seed and early-stage companies; connecting investors with their Investment Portfolio companies; expanding established life sciences ventures and relocating biomedical companies to Pennsylvania. For more information, visit www.plsg.com.

About Slater Technology Fund

The Slater Technology Fund is a state-backed venture capital fund that invests in new ventures committed to basing and building their businesses in Rhode Island. Slater focuses its resources on the support of entrepreneurs who have the vision, leadership and commitment to build substantial commercial enterprises. Slater typically invests at the inception stage in the development of a new venture, often based upon ideas and technologies originating in academic institutions and/or government research laboratories located within the region. In most cases, investments are premised upon the possibility of raising substantial follow-on financing, from venture capital investors or from strategic partners, with a view toward accelerating the generation of significant numbers of high-value, high-wage jobs over the intermediate to longer-term. For more information, visit www.slaterfund.com.


'/>"/>
SOURCE Pittsburgh Life Sciences Greenhouse
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Providence Service Corporation to Report Second Quarter 2009 Results on Monday, August 10th After the Market Closes
2. SecureWorks Closes Acquisition of VeriSigns Managed Security Services Business
3. BioMed Realty Trust Closes New $18 Million Secured Loan
4. I-Therapeutix, Inc. Closes $15 Million Financing
5. Savara Closes Series A Financing Round
6. Response Biomedical Closes $12.65 million Unit Offering
7. Swine Flu Closes Three Schools in NYC
8. Swine Flu Closes 3 Schools in NYC
9. Aethlon Medical Discloses New HIV/AIDS Treatment Data
10. ASA May Day - Stung By Exposure of Watergate-like Public Record Deletions, American Society of Anesthesiologists Closes Access to Website Newsletter
11. Providence Service Corporation to Report First Quarter 2009 Results on Wednesday, May 6th After the Market Closes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... 2016 , ... The Justin Veatch Fund announced Thursday that ... film Whispering Spirits and its discussion guide for use by all of ... in the war against teen drug abuse. NCADD is the oldest anti-addiction advocacy ...
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider of fully-automated ... new solution for Emergency Departments (ED) has been added to their portfolio. Housed ... examination rooms, and with a simplified pallet of information available to the patient, ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Research Institute (WCRI) officially opened registration today for its 33rd Annual Issues ... Boston, MA . , The theme of the conference is “Persistent Challenges and ...
(Date:12/8/2016)... ... 08, 2016 , ... CURE Media Group, the nation’s leading digital and print ... Upstage Lung Cancer in efforts to combat lung cancer, announced CURE Media Group President ... “CURE Media Group is honored to team up with Upstage Lung Cancer in order ...
(Date:12/8/2016)... ... 08, 2016 , ... Launching of the ... Instance Manager architecture, meeting the needs of multichannel growth and doubling the ... auto-dialing system without agents, Presence Robodialer, provides greater operational capacity, administrative flexibility ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016 Australia Glaucoma Surgery Devices Market ... report, "Australia Glaucoma Surgery Devices Market Outlook to ... Glaucoma Surgery Devices market. The report provides value, ... and average prices (USD) within market segement - ... company shares and distribution shares data for each ...
(Date:12/8/2016)... global biosurgery market is expected to grow at a ... to 2021. The market is poised to reach USD ... 2016. The market is primarily driven by rising number ... spinal problems, increasing clearance of biosurgery products by regulatory ... In this report, the biosurgery market is ...
(Date:12/8/2016)... Dec. 8, 2016 KEY FINDINGS ... grow in 2017-2023. Various reasons for growth of the ... higher incidences of chronic diseases, high recovery cost of ... services. Medical lifting sling refers to an assistive ... mobility. These slings connect to the lift and hold ...
Breaking Medicine Technology: